Natural Killer Cells

References

• Rosenberg E. B., Herberman R. B., Levine P. H., Halterman R. H., McCoy J. L., Wunderlich J. R. Lymphocyte cytotoxicity reactions to leukemia-associated antigens in identical twins. Int. J. Cancer 1972; 9: 648
   PubMedGoogle Scholar
• McCoy J. L., Herberman R. B., Rosenberg E. B., Donnelly F. C., Levine P. H., Alford C. “Chromium release assay for cell-mediated cytotoxicity of human leukemia and lymphoid tissue-culture cells. Natl. Cancer Inst. Monogr. 1973; 37: 59
   PubMedGoogle Scholar
• Pross H. F., Jondal M. Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes. Clin. Exp. Immunol. 1975; 21: 226
   PubMed Web of Science ®Google Scholar
• Pross H. F., Baines M. G. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. VI. A brief review. Cancer Immunol. Immunother. 1977; 3: 75
   Web of Science ®Google Scholar
• Herberman R. B., Holden H. T. Natural cell-mediated immunity. Adv. Cancer Res. 1978; 27: 305
   PubMedGoogle Scholar
• Herberman R. B., Djeu J. Y., Kay H. D., Ortaldo J. R., Riccardi C., Bonnard G. D., Holden H. T., Fagnani R., Santoni A., Purcetti P. Natural killer cells: characteristics and regulation of activity. Immunol. Rev. 1979; 44: 43
   PubMed Web of Science ®Google Scholar
• Herberman R. B., Ortaldo J. R. Natural killer cells: their role in defenses against disease. Science 1981; 214: 24
   PubMed Web of Science ®Google Scholar
• Biron C. A., Welsh R. M. Activation and role of natural killer cells in virus infections. Med. Microbiol. Immunol. 1982; 170: 155
   Google Scholar
• Zarling J. M., Eskra L., Borden E. C., Horoszewicz J., Carter W. A. Activation of human natural killer cells cytotoxic for human leukemia cells by purified interferon. J. Immunol. 1979; 123: 63
   PubMed Web of Science ®Google Scholar
• Hanna N., Fidler I. J. The role of natural killer cells in the destruction of circulating tumor emboli. J. Natl. Cancer Inst. 1980; 65: 801
   PubMed Web of Science ®Google Scholar
• Roder J. C., Pross H. F. The biology of the human natural killer cell. J. Clin. Immunol. 1982; 2: 249
   PubMed Web of Science ®Google Scholar
• Roder J. C., Haliotis T. Do NK cells play a role in anti-tumor surveillance?. Immunol. Today 1980; 1: 96
   PubMedGoogle Scholar
• Timonen T., Saksela E. Isolation of human natural killer cells by discontinuous gradient centrifugation. J. Immunol. Methods 1980; 36: 285
   PubMed Web of Science ®Google Scholar
• Timonen T., Reynolds C. W., Ortaldo J. R., Herberman R. B. Isolation of human and rat natural killer cells. J. Immunol. Methods 1982; 41: 269
   Google Scholar
• Timonen T., Ortaldo J. R., Herberman R. B. Analysis by a single cell cytotoxicity assay of natural killer (NK) cell frequencies among human large granular lymphocytes and of the effects of interferon on their activity. J. Immunol. 1982; 128: 2514
   PubMed Web of Science ®Google Scholar
• Carpen O., Virtanen I., Saksela E. infrastructure of human natural killer cells: nature of the cytolytic contacts in relation to cellular secretion. J. Immunol. 1982; 6: 2691
   Google Scholar
• Timonen T., Ortaldo J. R., Herberman R. B. Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J. Exp. Med. 1981; 153: 569
   PubMed Web of Science ®Google Scholar
• Rober J. C., Haliotis T., Klein M., Korec S., Jett J., Ortaldo J., Herberman R. B., Katz P., Fauci A. S. A new immunodeficiency disorder in humans involving NK cells. Nature (London) 1980; 284: 553
   Google Scholar
• Haliotis T., Roder J. C., Klein M., Ortaldo J., Fauci A. S., Herberman R. B. Chediak-Higashi gene in humans. I. Impairment of natural killer function. J. Exp. Med. 1980; 151: 1029
   Web of Science ®Google Scholar
• Abo T., Roder J. C., Abo W., Cooper M. D., Balch C. M. NK (HNK-1 +) cells in Chediak-Higashi patients are present in normal numbers but are abnormal in function and morphology. J. Clin. Invest. 1982; 70: 155
   Google Scholar
• Ortaldo J. R., Herberman R. B. Heterogeneity of natural killer cells. Annu. Rev. Immunol. 1984; 2: 365
   Google Scholar
• Breard J., Reinherz E. L., O'Brien C., Schlossman S. F. Delineation of an effector population responsible for natural killing and antibody-dependent cellular cytotoxicity in man. Clin. Immunol. Immunopathol. 1981; 18: 145
   PubMedGoogle Scholar
• Ortaldo J. R., Sharrow S. O., Timonen T., Herberman R. B. Analysis of surface antigens on highly purified human NK cells by flow cytometry with monoclonal antibodies. J. Immunol. 1981; 127: 2401
   PubMed Web of Science ®Google Scholar
• Reinherz E. L., Moretta L., Roper M., Breard J. M., Mingari M. C., Cooper M. D., Schlossman S. F. Human T lymphocyte subpopulations defined by Fc receptors and monoclonal antibodies. A comparison. J. Exp. Med. 1980; 151: 969
   PubMed Web of Science ®Google Scholar
• Perussia D., Acuto D., Terhorst C., Faust J., Lazarus R., Fanning V., Trinchieri G. Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor function. Studies of B73. 1 antibody-antigen interaction on the lymphocyte membrane. J. Immunol. 1983; 130: 2142
   PubMed Web of Science ®Google Scholar
• Ortaldo J. R., Herberman R. B. Heterogeneity of natural killer cells. Annu. Rev. Immunol. 1984; 2: 366
   Google Scholar
• Ferrarini M., Cadoni A., Franzi T., Ghigliotti C., Leprini A., Zicca A., Grossi C. E. Ultrastructural and cytochemical markers of human lymphocytes. Thymus, Thymic Hormones and T Lymphocytes, F. Aiuti. Plenum Press, New York 1980; 181
   Google Scholar
• Abo T., Balch C. M. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J. Immunol. 1981; 127: 1024
   PubMed Web of Science ®Google Scholar
• Reinherz E. L., Kung P. C., Goldstein G., Levey R. H., Schlossman S. F. Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc. Natl. Acad. Sci. U.S.A. 1980; 77: 1588
   PubMed Web of Science ®Google Scholar
• Chang Z. L., Hoffman T., Bonvini E., Stevenson H. C., Herberman R. B. Spontaneous cytotoxicity of human and mouse tumor cell lines by peripheral blood mononuclear cells: contributions of adherent and nonadherent NK-like cells. Scand. J. Immunol., in press
   Google Scholar
• West W. H., Cannon G. B., Kay H. D., Bonnard G. D., Herberman R. B. Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: characterization of effector cells. J. Immunol. 1977; 118: 355
   PubMed Web of Science ®Google Scholar
• Toivanen P., Uksila J., Leino A., Lassila O., Hirvonen T., Ruuskanen O. Development of mitogen responding T cells and natural killer cells in the human fetus. Immunol. Rev. 1981; 57: 89
   PubMed Web of Science ®Google Scholar
• Baines M. G., Pross H. F., Millar K. G. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IV. The suppressive effect of normal pregnancy. Am. J. Obstet. Gynecol. 1978; 130: 741
   PubMed Web of Science ®Google Scholar
• Fernandes G., Gupta S. Natural killing and antibody-dependent cytotoxicity by lymphocyte subpopulations in young and aging humans. J. Clin. Immunol. 1981; 1: 141
   Google Scholar
• Penschow J., MacKay I. R. NK and K cell activity of human blood: differences according to sex, age, and disease. Ann. Rheum. Dis. 1980; 39: 82
   Google Scholar
• Antonelli P., Stewart W., Dupont B. Distribution of natural killer cell activity in peripheral blood, cord blood, thymus, lymph nodes, and spleen and the effect of in vivo treatment with interferon preparation. Clin. Immunol. Immunopalhol. 1981; 19: 161
   Google Scholar
• Forbes J. T., Niblack G. D., Fuchs R., Richie R. E., Johnson H. K., Oldham R. K. Human natural cell mediated cytotoxicity. I. Levels in peripheral blood, cord blood, and thoracic duct lymphocytes. Cancer Immunol. Immunother. 1981; 11: 139
   Google Scholar
• Targan S. R., Gale R. P., Jondal M. Bone marrow modulation of spontaneous killer cellular cytotoxicity (SKCC) induction. J. Clin. Lab. Immunol. 1980; 4: 1
   Google Scholar
• Kedar E., Ikejiri B. L., Timonen T., Bonnard G. D., Reid J., Navarro N. J., Sredni B., Herberman R. B. Antitumor reactivity in vitro and in vivo of lymphocytes from normal donors and cancer patients propagated in culture with T-cell growth factor (TCGF). Eur. J. Cancer Clin. Oncol. 1983; 19: 757
   Google Scholar
• Timonen T., Ortaldo J. R., Stadler B. M., Bonnard G. D., Sharrow S. O., Herberman R. B. Cultures of purified human natural killer cells: growth in the presence of interleukin 2. Cell Immunol. 1982; 72: 178
   PubMed Web of Science ®Google Scholar
• Timonen T., Ortaldo J. R., Vose B. M., Henkart M., Alvarez J., Hergerman R. B. Cultures of human natural killer cells (large granular lymphocytes) and T cells in the presence of interleukin-2 containing conditioned medium. J. Reticuloendothel. Soc. 1983; 33: 67
   Google Scholar
• Seeley J. K., Golub S. H. Studies on cytotoxicity generated in human mixed lymphocyte cultures. J. Immunol. 1978; 120: 1415
   PubMed Web of Science ®Google Scholar
• Ortaldo J. R., Bonnard G. D., Kind P. D., Herberman R. B. Cytotoxicity by cultured human lymphocytes: characteristics of effectors and specificity of cytotoxicity. J. Immunol. 1979; 122: 1489
   PubMedGoogle Scholar
• Grimm E. A., Mazumder A., Zhang H. Z., Rosenberg S. A. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J. Exp. Med. 1982; 155: 1823
   PubMed Web of Science ®Google Scholar
• Klein E., Vanky F. Natural inactivated cytotoxic lymphocytes which act on autologous and allogeneic tumor cells. Cancer Immunol. Immunother. 1981; 11: 183
   Google Scholar
• Ortaldo J. R., Herberman R. B. Heterogeneity of natural killer cells. Annu. Rev. Immunol. 1984; 2: 370
   Google Scholar
• Allavena R., Ortaldo J. R. Specificity and phenotype of IL-2 expanded clones of human large granular lymphocytes. Diagn. Immunol. 1983; 1: 162
   Google Scholar
• Allavena P., Ortaldo J. R. Characteristics of human NK clones: target specificity and phenotype. J. Immunol. 1984; 132: 2363
   Google Scholar
• Moretta L., Mingari M. C., Sekaly P. R., Moretta A., Chapuis B., Cerottini J. C. Surface markers of cloned human T cells with various cytolytic activities. J. Exp. Med. 1981; 154: 569
   PubMed Web of Science ®Google Scholar
• Baldwin R. W. Role of immunosurveillance against chemically induced rat tumors. Transplant. Rev. 1976; 28: 62
   Google Scholar
• Cudkowicz G., Hochman P. S. Do natural killer cells engage in regulated reactions against self to ensure homeostasis?. Immunol. Rev. 1979; 44: 13
   PubMed Web of Science ®Google Scholar
• Herberman R. B. Cell-mediated immunity to tumor cells. Adv. Cancer Res. 1974; 19: 207
   PubMedGoogle Scholar
• Nunn M. E., Herberman R. B., Holden H. T. Natural cell-mediated cytotoxicity in mice against non-lymphoid tumor cells and some normal cells. Int. J. Cancer 1977; 20: 381
   Google Scholar
• Herberman R. B., Nunn M. E., Lavrin D. H. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and aldogeneic tumors. I. Distribution of reactivity and specificity. Int. J. Cancer. 1975; 16: 216
   PubMed Web of Science ®Google Scholar
• Kay H. D., Bonnard G. D., West W. H., Herberman R. B. A functional comparison of human Fc-receptor-bearing lymphocytes active in natural cytotoxicity and antibody-dependent cellular cytotoxicity. J. Immunol. 1977; 118: 2058
   PubMed Web of Science ®Google Scholar
• Vanky F. T., Argov S. A., Einhorn S. A., Klein E. Role of alloantigens in natural killing. Allogeneic but not autologous tumor biopsy cells are sensitive for interferon-induced cytotoxicity of human blood lymphocytes. J. Exp. Med. 1980; 151: 1151
   Google Scholar
• Kabelitz D., Kunkel H. G. Phorbol ester-treated human lymphocytes are susceptible to natural killer cell-mediated cytolysis. J. Immunol. 1983; 130: 2505
   Google Scholar
• Phillips W. H., Ortaldo J. R., Herberman R. B. Selective depletion of human natural killer cells on monolayers of target cells. J. Immunol. 1980; 125: 2322
   Google Scholar
• Jensen P. J., Koren H. S. Depletion of NK by cellular immunoadsorption. j. Immunol. 1979; 123: 1127
   Google Scholar
• Roder J. C., Ahrlund-Richter L., Jondal M. Target-effector interaction in the human and murine natural killer system. Specificity and xenogeneic reactivity of solubilized natural killer-target structure complex and its loss in a somatic cell hybrid. J. Exp. Med. 1979; 150: 471
   Google Scholar
• Ortaldo J. R., Herberman R. B. Heterogeneity of natural killer cells. Annu. Rev. Immunol. 1984; 2: 374
   Google Scholar
• Ortaldo J. R., Lewis J. T., Braatz J., Mason A., Henkart P. Isolation of target antigens from NK-susceptible targets. Proc. 15th Leukocyte Culture Conf. John Wiley & Sons, London 1983; 551
   Google Scholar
• Vodinelich L., Sutherland R., Schneider C., Newman R., Greaves M. Receptor for transferrin may be a “target” structure for natural killer cells. Proc. Natl. Acad. Sci. U.S.A. 1983; 80: 835
   Google Scholar
• Trowbridge I. S., Omary M. B. Human cell surface of glycoprotein related to cell proliferation is the receptor for transferrin. Proc. Natl. Acad. Sci. U.S.A. 1981; 78: 3039
   PubMed Web of Science ®Google Scholar
• Sutherland R., Delia D., Schneider C., Newman R., Kemshead J., Greaves M. Ubiquitous cell-surface glycoprotein on tumor cells is proliferation associated receptor for transferrin. Proc. Natl. Acad. Sci. U.S.A. 1981; 78: 4515
   PubMed Web of Science ®Google Scholar
• Bridges K. R., Smith B. R. Transferrin receptor expression does not dictate susceptibility to lysis by natural killer cells. Blood (Suppl.) 1984; 64: 76a, (Abstr.)
   Google Scholar
• Herberman R. B., Ortaldo J. R., Bonnard G. D. Augmentation by interferon of human natural and antibody dependent cell-mediated cytotoxicity. Nature (London) 1979; 277: 221
   PubMed Web of Science ®Google Scholar
• Trinchieri G., Santoli D. Enhancement of human natural killer cell activity by interferon. J. Immunol. 1978; 120: 1845
   Google Scholar
• Ulberg M., Jondal M. Human NK cell activation with interferon and with target cell-specific IgG. NK Cells and Other Natural Effector Cells, R. B. Herberman. Academic Press, New York 1982; 361
   Google Scholar
• Wolfe S. A., Tracey D. E., Henney C. S. Induction of “natural killer” cells by BCG. Nature (London) 1976; 262: 584
   PubMed Web of Science ®Google Scholar
• Roder J. C., Karre K., Kiessling R. Natural killer cells. Prog. Allergy 1981; 28: 66
   PubMedGoogle Scholar
• Henney C. S., Kuribayashi K., Kern D. E., Gillis S. Interleukin-2 augments natural killer cell activity. Nature (London) 1981; 291: 335
   PubMed Web of Science ®Google Scholar
• Morgan D. A., Rusceth F. W., Gello R. C. Selective in vitro growth of T-lymphocytes from normal human bone marrows. Science 1978; 193: 1007
   Web of Science ®Google Scholar
• Robb R. J., Munck A., Smith K. A. T cell growth factor receptors. Quantitation, specificity and biological relevance. J. Exp. Med. 1981; 154: 1455
   PubMed Web of Science ®Google Scholar
• Watson J. D., Mochizuki D. Y., Gillis S. Molecular characterization of interleukin 2. Fed. Proc. Fed. Am. Soc. Exp. Biol. 1983; 42: 2747
   PubMedGoogle Scholar
• Domzig W., Stadler B. M., Herberman R. B. Interleukin-2 dependence of human natural killer (NC) cell activity. J. Immunol. 1983; 130: 1970
   PubMed Web of Science ®Google Scholar
• Ortaldo J. R., Gerard J. P., Henderson L. E., Neubauer R. H., Rabin H. Responsiveness of purified natural killer cells to pure interleukin-2, (IL-2). Interleukins, Lymphokines, and Cytokines, J. J. Oppenheim, H. Rabin. Academic Press, New York 1983; 63
   Google Scholar
• Weigent D. A., Stanton G. H., Johnson H. M. Interleukin 2 enhances natural killer cell activity through induction of gamma interferon. Infect. Immunol. 1983; 41: 992
   PubMed Web of Science ®Google Scholar
• Droller M. J., Schneider M. U., Perlmann P. A possible role of prostaglandins in the inhibition of natural and antibody-dependent cell-mediated cytotoxicity against tumor cells. Cell Immunol. 1978; 39: 165
   PubMed Web of Science ®Google Scholar
• Parrillo J. E., Fauci A. S. Comparison of the effector cells in human spontaneous cellular cytotoxicity and antibody dependent cellular cytotoxicity: differential sensitivity of effector cells to in vivo, in vitro corticosteroids. Scand. J. Immunol. 1978; 8: 99
   PubMedGoogle Scholar
• Weitzer M. L., Bonavida B. Mechanism of inhibition of human natural killer activity by ultraviolet radiation. J. Immunol. 1984; 133(3)28
   Google Scholar
• El-Hag A., Clark R. A. Down-regulation of human natural killer activity against tumors by the neutrophil myeloperoxidase system and hydrogen peroxide. J. Immunol. 1984; 133: 3291
   PubMed Web of Science ®Google Scholar
• Roder J. L., Kiessling R., Biberfeld R., Anderson T. B. Target effector interaction in the natural killer (NK) system. II. The isolation of NK cells and studies on the mechanism of killing. J. Immunol 1978; 121: 2509
   PubMed Web of Science ®Google Scholar
• Targan S., Dorey F. Interferon activation of “pre-spontaneous killer” (pre-SK) cells and alteration in kinetics of lysis of both “pre-SK” and active SK cells. J. Immunol 1980; 124: 2157
   PubMedGoogle Scholar
• Hiserodt J. C., Britan L., Targan S. R. Studies on the mechanism of the human natural killer cell lethal hit: analysis of the mechanism of protease inhibition of the lethal hit. J. Immunol. 1983; 131: 2705
   Google Scholar
• Hiserodt J. C., Britan L., Targan S. R. Studies on the mechanism of the human natural killer cell lethal hit: evidence for the transfer of protease sensitive structures requisite for target cell lysis. J. Immunol. 1983; 131: 2710
   Google Scholar
• Hiserodt J. C., Britran L. J., Targan S. R. Characterization of the cytolytic reaction mechanism of the human natural killer (NK) lymphocyte: resolution into binding, programming and killer cell-independent steps. J. Immunol. 1982; 129: 1782
   PubMed Web of Science ®Google Scholar
• Henkart M. P., Timonen T., Mill P. J., Henkart P. A. Role of lymphocyte cytoplasmic granules in ADCC and NK killing. Fed. Proc. Fed. Am. Soc. Exp. Biol. 1982; 41: 475
   Google Scholar
• Blumenthal R., Millard P. J., Henkart M. P., Reynolds C. W., Henkart P. A. Liposomes as targets for granule cytolysis from cytotoxic large granular lymphocyte tumors. Proc. Natl Acad. Sci. U.S.A. 1984; 81: 5551
   Google Scholar
• Procopio A. D. C., Scala G., Herberman R. B., Oppenheim J. J., Ortaldo J. R. Production of B-cell growth factor (BCGF) by human large granular lymophcytes (LGL). Fed. Proc. Fed. Am. Soc. Exp. Biol., in press
   Google Scholar
• Farrum E., Targan S. R. Identification of human natural killer soluble cytotoxic factors (NKCF) derived from NK-enriched lymphocyte populations: specificity of generation and killing. J. Immunol. 1983; 130: 1252
   Google Scholar
• Djeu J. Y., Timonen T., Herberman R. B. Production of interferon by human natural killer cells in response to mitogens, viruses and bacteria. NK Cells and Other Natural Effector Cells, R. B. Herberman. Academic Press, New York 1982; 669
   Google Scholar
• Kasahara T., Djeu J. Y., Dougherty S. F., Oppenheim J. J. Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: interleukin 2, interferon and colony stimulating factor. J. Immunol. 1983; 131: 2379
   PubMed Web of Science ®Google Scholar
• Ortaldo J. R., Herberman R. B. Heterogeneity of natural killer cells. Annu. Rev. Immunol. 1984; 2: 379
   Google Scholar
• Pross H. F., Baines M. G. Studies of human natural killer cells. I. In vivo parameters affecting normal cytotoxic function. Int. J. Cancer 1982; 29: 383
   PubMed Web of Science ®Google Scholar
• Seaman W. E., Blackman M. A., Gindhert T. D., Roubinian J. R., Loeb J. M., Talal N. β-estradiol reduces natural killer cells in mice. J. Immunol. 1978; 121: 2193
   PubMed Web of Science ®Google Scholar
• Hanna N., Schneider M. Enhancement of tumor metastasis and suppression of natural killer cell activity by β-estradiol treatment. J. Immunol. 1983; 130: 974
   PubMed Web of Science ®Google Scholar
• Rubin P., Pross H. F., Roder J. C. Studies of human natural killer cells. II. Analysis of the single cell level. J. Immunol. 1982; 128: 2553
   Google Scholar
• Roder J. C., Kiessling R. Target-effector interaction in the natural killer cell system. I. Co-variance and genetic control of cytolytic and target-cell-binding subpopulations in the mouse. Scand. J. Immunol. 1978; 8: 135
   PubMed Web of Science ®Google Scholar
• Roder J. C., Duwe A. K. The beige mutation in the mouse selectively impairs NK cell function. Nature (London) 1979; 278: 451
   PubMed Web of Science ®Google Scholar
• Clark E., Windsor N. T., Sturge J., Stanton T. H. Mutations that influence natural cell-mediated cytotoxicity in rodents. Natural Cell Mediated Immunity Against Tumors, R. B. Herberman. Academic Press, New York 1980; 417
   Google Scholar
• Santoli D., Trinchieri G., Zimjewski C. M., Koprowski H. HLA-related control of spontaneous and antibody-dependent cell-mediated cytotoxic activity in humans. J. Immunol. 1976; 117: 765
   PubMed Web of Science ®Google Scholar
• Petranyi G., Benczur M., Onody C., Hollan S. R. HLA-3, 7 and lymphocyte cytotoxic activity. Lancet 1974; 1: 736
   Google Scholar
• Hersey P., Edwards A., Honeyman M., McCarthy W. H. Low natural-killer-cell activity in familial melanoma patients and their relatives. Br. J. Cancer 1979; 40: 113
   PubMed Web of Science ®Google Scholar
• Pross H. F., Baines M. G. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. I. The effect of malignant disease. Int. J. Cancer. 1976; 18: 593
   PubMed Web of Science ®Google Scholar
• Forbes J. T., Greco F. A., Oldham R. K. Human natural cell-mediated cytotoxicity. II. Levels in neoplastic disease. Cancer Immunol. Immunother. 1981; II: 147
   Google Scholar
• DeBoer K. P., Braun D. P., Harris J. E. Natural cytotoxicity and antibody-dependent cytotoxicity in solid tumor cancer patients: regulation by adherent cells. Clin. Immunol. Immunopathol. 1982; 23: 133
   PubMedGoogle Scholar
• Siegal F. P., Lopez C., Hammer G. S., Brown A. E., Kornfeld S. J., Gold J., Hasset J., Hirschman S. Z., Cunningham-Rundles C., Adelsberg B. R., Parham D. M., Siegal M., Cunningham-Rundles S., Armstrong D. Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. New Engl. J. Med. 1981; 305: 1439
   PubMed Web of Science ®Google Scholar
• McGeorge M. B., Russell E. C., Mohanakumar T. Immunologic evaluation of long term effects of childhood ALL chemotherapy: analysis of in vitro NK- and K-cell activities of peripheral blood lymphocytes. Am. J. Hematol. 1982; 12: 19
   PubMed Web of Science ®Google Scholar
• Behelak U., Banerjee D., Richter M. Immunocompetent cell in patients with malignant disease. I. The lack of naturally occurring killer cell activity in the unfractionated circulating lymphocytes from patients with chronic lymphocytic leukemia (CLL). Cancer 1976; 38: 2274
   Google Scholar
• Ziegler H. W., Kay N. E., Zarling J. M. Deficiency of natural killer cell activity in patients with chronic lymphocytic leukemia. Int. J. Cancer 1981; 27: 321
   PubMed Web of Science ®Google Scholar
• Lang I., Taraba I., Petrany G. Decreased antibody-dependent and spontaneous cell-mediated cytotoxicity in patients with chronic renal failure. Immunol. Lett. 1981; 3: 267
   Google Scholar
• Karsh J., Dorval G., Osterland C. K. Natural cytotoxicity in rheumatoid arthritis and systemic lupus erythematosus. Clin. Immunol. Immunopathol. 1981; 19: 437
   PubMedGoogle Scholar
• Seybold D., Ryan E. A., Wall J. R. Natural cytotoxicity of blood mononuclear cells from normal subjects and patients with Hashimoto's thyroiditis against normal thyroid cells. J. Clin. Lab. Immunol. 1981; 6: 241
   Google Scholar
• Santoli D., Hall W., Kastrukoff L., Lisak R. P., Perussia B., Trinchieri G., Koprowski H. Cytotoxic activity and interferon production by lymphocytes from patients with multiple sclerosis. J. Immunol 1981; 126: 1274
   PubMedGoogle Scholar
• Cunningham-Rundles S., Filippa D. A., Braun D. W., Jr., Antonelli P., Ashikari H. Natural cytotoxicity of peripheral blood lymphocytes and regional lymph node cells in breast cancer in women. J. Natl. Cancer Inst. 1981; 67: 585
   Google Scholar
• Leung D. Y. M., Parkman R., Feller J., Wood N., Geha R. S. Cell-mediated cytotoxicity against skin fibroblasts in atopic dermatitis. J. Immunol. 1982; 128: 1736
   Google Scholar
• Guillou P. J., Hegarty J., Ramsden C., Davison A. M., Will E. J., Giles G. R. Changes in human natural killer activity early and late after renal transplantation using conventional immunosuppression. Transplantation 1982; 33: 414
   Google Scholar
• Dokhelar M. C., Wiels J., Lipinski M., Tetaud C., Devergie A., Gluckman E., Tursz T. Natural killer cell activity in human bone marrow recipients. Early appearance of peripheral natural killer activity in graft-versus-host disease. Transplantation 1981; 31: 61
   PubMed Web of Science ®Google Scholar
• Dienstag J. L., Bhan A. K. Enhanced in vitro cell-mediated cytotoxicity in chronic hepatitis B virus infection: absence of specificity for virus expressed antigen on target cell membranes. J. Immunol. 1980; 125: 2269
   Google Scholar
• Ennis F. A., Meager A., Beare A. S., Yi-Hua Q., Riley D., Schwarz G., Schild G. C., Rook A. H. Interferon induction and increased natural killer-cell activity in influenza infections in man. Lancet 1981; 1: 891
   Google Scholar
• Ojo-Amaize E. A., Salimonu L. S., Williams A. I. O., Akinwolere O. A. O., Shabo R., Alm S. G., Wigzell H. Positive correlation between degree of parasitemia, interferon titers, and natural killer cell activity in Plasmodium falciparum-infected children. J. Immunol. 1981; 127: 2296
   PubMed Web of Science ®Google Scholar
• Sullivan J. L., Byron K. S., Brewster F. F., Purtilo D. Deficient natural killer cell activity in X-linked lymphoproliferative syndrome. Science 1980; 210: 543
   PubMed Web of Science ®Google Scholar
• Klein M., Roder J., Haliotis T., Korec S., Jett J., Herberman R. B., Katz P., Fauci A. S. Chediak-Higashi gene in humans. II. The selectivity of the defect in natural-killer and antibody dependent cell-mediated cytotoxicity function. J. Exp. Med. 1980; 151: 1049
   PubMed Web of Science ®Google Scholar
• Dent P. B., Fish L. A., White J. F., Good R. A. Chediak-Higashi syndrome. Observations on the nature of the associated malignancy. Lab. Invest. 1966; 15: 1634
   PubMed Web of Science ®Google Scholar
• Pross H. F., Gupta S., Good R. A., Baines M. Spontaneous human lymphocyte mediated cytotoxicity against tumor target cells. VII. The effect of immunodeficiency disease. Cell Immunol. 1979; 43: 160
   Google Scholar
• Lipinski M., Virilizier J. L., Tursz T., Griscelli C. Natural killer and killer cell activities in patients with primary immunodeficiencies or defects in immune interferon production. Eur. J. Immunol. 1980; 10: 246
   PubMed Web of Science ®Google Scholar
• Nelson D. Lymphocyte-mediated cytotoxicity in immunodeficiency patients. Primary Immunodeficiencies, M. Seligmann, W. Hitzic. Elsevier/North-Holland, New York 1980; 141
   Google Scholar
• Kay N. E., Zarling J. Z. Impaired natural killer activity in patients with chronic lymphocytic leukemia is associated with a deficiency of azurophilic cytoplasmic granules in putative NK cells. Blood 1984; 63: 305
   PubMed Web of Science ®Google Scholar
• Rumpold H., Kraft D., Obexer G., Bock G., Gebhard W. A monoclonal antibody against a surface antigen shared by human large granular lymphocytes and granulocytes. J. Immunol. 1982; 129: 1458
   PubMed Web of Science ®Google Scholar
• Abo T., Balch C. M. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J. Immunol. 1981; 127: 1024
   PubMed Web of Science ®Google Scholar
• Ziegler-Heitbrock H. W. L., Rumpold H., Kraft D., Wagenpfeil C., Munker R., Abo T., Balch C. M., Le Bien T. W. Patients with a deficiency of natural killer cell activity lack the VEP13-positive lymphocyte subpopulation. Blood 1985; 65: 65
   Google Scholar
• Blume R. S., Wolff S. M. The Chediak-Higashi syndrome: studies in four patients and a review of the literature. Medicine (Baltimore) 1972; 51: 247
   PubMed Web of Science ®Google Scholar
• Haliotis T., Roder J., Klein M., Ortaldo J., Fauci A. S., Herberman R. B. Chediak-Higashi gene in humans. I. Impairment of natural killer function. J. Exp. Med. 1980; 151: 1039
   PubMed Web of Science ®Google Scholar
• Katz P., Zaytoun A. M., Fauci A. S. Deficiency of active natural killer cells in the Chediak-Higashi syndrome. J. Clin. Invest. 1982; 69: 1231
   PubMed Web of Science ®Google Scholar
• Targan S. R., Oseas R. The “lazy” NK cells of Chediak-Higashi syndrome. J. Immunol. 1983; 130: 2671
   Google Scholar
• Kasai M., Leclerc J. C., McKay-Boudreau L., Shen F. W., Cantor H. Direct evidence that natural killer cells in nonimmune spleen cell populations prevent tumor growth in vivo. J. Exp. Med. 1979; 149: 1260
   PubMedGoogle Scholar
• Kadish A. S., Doyle A. T., Steinhauer E. H., Ghossein N. A. Natural cytotoxicity and interferon production in human cancer: deficient natural killer activity and normal interferon production in patients with advanced disease. J. Immunol. 1981; 127: 1817
   PubMed Web of Science ®Google Scholar
• Steinhauer E. H., Doyle A. T., Reed J., Kadish A. S. Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease. J. Immunol. 1982; 129: 2255
   PubMed Web of Science ®Google Scholar
• Ruco L. P., Procopio A., Uccini S., Marcorelli E., Baroni C. D. Natural killer activity in spleens and lymph nodes from patients with Hodgkin's disease. Cancer Res. 1982; 42: 2063
   Google Scholar
• Chang K. S. S., Log T. Natural killer cell activity associated with reticulum cell neoplasms. Int. J. Cancer 1980; 25: 405
   Google Scholar
• Vchida A., Yagita M., Sugiyama H., Hoshino T., Moore M. Strong natural killer (NK) cell activity in bone marrow of myeloma patients: accelerated maturation of bone marrow NK cells and their interaction with other bone marrow cells. Int. J. Cancer 1984; 34: 375
   Google Scholar
• Minato N., Takeda A., Kano S., Takaku F. Studies of the function of natural killer-interferon system in patients with Sjogren syndrome. J. Clin. Invest. 1982; 69: 581
   PubMed Web of Science ®Google Scholar
• Hoffman T. Natural killer function in systemic lupus erythematosus. Arthritis Rheum. 1980; 23: 30
   PubMedGoogle Scholar
• Katz P., Zaytoun A. M., Lee J. H., Panush R. S., Longley S. Abnormal natural killer activity in systemic lupus erythematosus: an intrinsic defect in the lytic event. J. Immunol. 1982; 129: 1966
   PubMed Web of Science ®Google Scholar
• Rook A. H., Stocks N., Tsokos G. C., Balow J. E., Guinnan G. R., Djeu J. Y. Immunoglobulin G autoantibodies to natural killer cells in systemic lupus erythematosus. Clin. Res. 1981; 29: 488A
   Google Scholar
• Biron C. A., Turgiss L. R., Welsh R. M. Increase in NK cell number and turnover rate during acute viral infection. J. Immunol. 1983; 131: 1539
   PubMed Web of Science ®Google Scholar
• Bukowski J. F., Woda B. A., Habu S., Okumura K., Welsh R. M. Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J. Immunol. 1983; 131: 1531
   PubMed Web of Science ®Google Scholar
• Steele R. W., Vincent M. M., Hensen S. A., Fucillo D. A., Chapa I. A., Canalesh L. Cellular immune response to herpes simplex virus type 1 in recurrent herpes labialis: in vitro blastogenesis and cytotoxicity to infected cell lines. J. Infect. Dis. 1975; 131: 528
   PubMed Web of Science ®Google Scholar
• Thong Y. H., Hensen S. A., Vincent M. M., Fucillo D. A., Stiles W. A., Bellanti J. A. Use of cryopreserved virus infected target cells in a lymphocytotoxicity 51Cr release microassay for cell-mediated immunity to cytomegalovirus. Infect. Immunol. 1976; 13: 643
   Google Scholar
• Quinnan G. V., Kirmani N., Esber E., Saral R., Manis-Chewitz J. F., Rogers J. L., Rook A. H., Santos G. W., Burns W. H. HLA restricted cytotoxic T lymphocyte and nonthymic cytotoxic lymphocyte responses to cytomegalovirus infection of bone marrow transplant recipients. J. Immunol. 1981; 126: 2036
   PubMed Web of Science ®Google Scholar
• Yasukawa M., Zarling J. M. Autologous herpes simplex infected cells are lyzed by human natural killer cells. J. Immunol. 1983; 131: 2011
   Google Scholar
• Yasukawa M., Zarling J. M. Human cytotoxic T cell clones directed against herpes simplex virus infected cells. I. Lysis restricted by HLA class II MB and DR antigens. J. Immunol. 1984; 133: 422
   PubMed Web of Science ®Google Scholar
• Gastl G., Nederwieser D., Marth C., Huber H., Egg D., Shuler G., Margrether R., Braunsteiner H., Huber C. Human large granular lymphocytes and their relationship to natural killer and cell activity in various disease states. Blood 1984; 64: 288
   Google Scholar
• Kiessling R., Wigzell H. An analysis of the murine NK ceil as to structure, function and biological relevance. Immunol. Rev. 1979; 44: 165
   PubMed Web of Science ®Google Scholar
• Barlozzari T., Leonhardt J., Wiltrout R. H., Herberman R. B., Reynolds C. W. Direct evidence for the role of NK cells in the inhibition of tumor metastasis. J. Immunol. 1985; 134: 2783
   PubMed Web of Science ®Google Scholar
• Karre K., Klein G. O., Kiessling R., Klein G., Roder J. C. Low natural in vivo resistance to syngeneic leukemias in natural killer deficient mice. Nature (London) 1980; 284: 624
   Google Scholar
• Salomon J. C., Goldberg N. C., Lynch N. R. Cancer induction by methylcholanthrene and metastatic spread of transplantable tumors in Chediak-Higashi (beige) mice. Cancer Immunol. Immunother. 1980; 7: 67
   Google Scholar
• Gorczinski R. M. Evidence for in vivo protection against murine sarcoma virus-induced tumors by T lymphocytes from immune animals. J. Immunol. 1974; 112: 533
   Google Scholar
• Collins J. L., Patek P. O., Cohn M. Tumorigenicity and lysis by natural killers. J. Exp. Med. 1981; 153: 89
   PubMed Web of Science ®Google Scholar
• Hanna N., Fidler I. J. Relationship between metastatic potential and resistance to natural killer cell-mediated cytotoxcity in three murine tumor systems. J. Natl. Cancer Inst. 1981; 66: 1183
   Google Scholar
• Hanna N., Burton R. C. Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastasis in vivo. J. Immunol. 1981; 127: 1754
   PubMed Web of Science ®Google Scholar
• Waldmann T. A., Strober W., Blaese R. M. T and B Cell Immunodeficiency Diseases in Clinical Immunology, C. W. Parker. W. B. Saunders, Philadelphia 1980; Vol. 1: 356
   Google Scholar
• Hersey P., Edwards A., Milton G. W., McCarthy W. H. Relationship of cell-mediated cytotoxicity against melanoma cells to prognosis in melanoma patients. Br. J. Cancer 1978; 37: 505
   Google Scholar
• Werkmeister J. A., Pihl E., Nind A. A. P., Flannery G. R., Nairn R. C. Immunoreactivity by intrinsic lymphoid cells in colorectal carcinoma. Br. J. Cancer 1979; 40: 839
   Google Scholar
• Vose B. M., Moore M. Natural cytotoxicity in humans: susceptibility of freshly isolated tumor cells to lysis. J. Natl. Cancer Inst. 1980; 65: 257
   Google Scholar
• Vose B. M., Vanky F., Argov S., Klein E. Natural cytotoxicity in man: activity of lymph node and tumor infiltrating lymphocytes. Eur. J. Immunol. 1977; 7: 753
   Google Scholar
• Moore M., Vose B. M. Extravascular natural cytotoxicity in man: anti-K562 activity of lymph node and tumor infiltrating lymphocytes. Int. J. Cancer 1981; 27: 265
   PubMedGoogle Scholar
• Eremin O., Coombs R. R. A., Ashby J. Lymphocytes infiltrating human breast cancers lack K-cell activity and show low levels of NK-cell activity. Br. J. Cancer 1981; 44: 166
   PubMed Web of Science ®Google Scholar
• Vanky F. T., Argov S. A., Einhorn S. A., Klein E. Role of alloantigens in natural killing. Allogeneic but not autologous tumor biopsy cells are sensitive for interferon-induced cytotoxicity of human blood lymphocytes. J. Exp. Med. 1980; 151: 1151
   Google Scholar
• Gronberg A., Kiessling R., Eriksson E., Hansson M. Variants from a MLV-induced lymphoma selected for decreased sensitivity to NK lysis. J. Immunol. 1981; 127: 1734
   Google Scholar
• Durdik J. M., Beck B. N., Clark E. A., Henney C. S. Characterization of a lymphoma cell variant selectively resistant to natural killer cells. J. Immunol. 1980; 125: 683
   Google Scholar
• Bankhurst A. D. The modulation of human natural killer cell activity by prostaglandins. J. Clin. Lab. Immunol. 1982; 7: 85
   PubMedGoogle Scholar